Company Directory

Polymer-embedded antimicrobial technology for infection prevention in medical devices

Zonova is a biotech company developing patented antimicrobial technology embedded into medical device polymers at the manufacturing stage. The technology creates a protective surface that continuously kills a broad spectrum of pathogens, including drug-resistant strains such as MRSA. Applications span catheters, cannulas, endotracheal tubes, and surgical sutures. Zonova's commercial model is B2B licensing to medical device manufacturers, within a One Health approach to tackling antimicrobial resistance.

Bio-inspired adhesion peptides for medical and industrial use

Zentraxa is a biomaterials company engineering bio-inspired adhesion peptides using a proprietary synthetic peptide manufacturing platform. Inspired by marine mollusc chemistry, the platform designs and produces novel peptides with exceptional adhesion properties in wet and submerged environments. Medical applications include advanced wound dressings and ostomy bag seals. The company also develops performance-enhancing peptide ingredients for industrial and personal care sectors.

Enzymatic wound debridement therapy derived from maggot biology

SolasCure is a biotechnology company developing a recombinant enzyme-based hydrogel for the treatment of chronic wounds. The lead product contains a protease cloned from medical maggots that degrades non-viable wound tissue including fibrin, elastin, and collagen to prepare the wound bed for healing. The product is in Phase II clinical development for venous leg ulcers, with anti-biofilm activity as a secondary indication under investigation.

Speciality enzyme discovery, development, and commercial-scale manufacture

Biocatalysts is a Welsh industrial biotechnology company specialising in the discovery, development, and commercial-scale manufacture of speciality enzymes. Operating from fermentation and downstream processing facilities in Nantgarw, the company serves food and beverage, pharmaceutical, and life science industries with both catalogue enzyme products and bespoke custom development services. Its metagenomics platform supports novel enzyme discovery. Biocatalysts is a wholly owned subsidiary of BRAIN Biotech AG and holds multiple international quality and food safety certifications.

Ex vivo human skin models for pharmaceutical and cosmetic testing

Ten Bio is a contract research organisation providing ex vivo human skin research services to pharmaceutical, cosmetic, and medical device companies. Its patented platform mechanically tensions surgically sourced human skin to replicate the mechanobiology of intact living tissue, maintaining viability for up to two weeks. Applications include topical drug delivery, transdermal absorption, wound healing, aesthetic treatments, and pre-clinical safety testing, offering a human-relevant alternative to animal models.

Medical-grade collagen biomaterials for regenerative medicine devices

Evergen develops, manufactures, and supplies medical-grade collagen biomaterials and engineered tissue scaffolds for use in medical devices and regenerative medicine. Operating from Glasgow under GMP conditions, the company partners with OEM medical device manufacturers to develop and supply collagen formulations including solutions, gels, films, membranes, and sponges. Applications include orthopaedics, cardiovascular repair, wound care, plastic surgery, and spinal surgery. The company provides contract manufacturing, technology transfer, and regulatory support services.

Novel antibiotic-sparing therapeutics for chronic wound care

ONYA Therapeutics is a biotechnology company developing novel pharmaceutical treatments for acute and chronic wounds. The company's pipeline centres on a patented controlled-release drug delivery technology designed to manage wound exudate and reduce reliance on antibiotics, addressing antimicrobial resistance in wound care settings. Lead assets are progressing through pre-clinical and early clinical development, targeting chronic wounds including diabetic foot ulcers. ONYA serves healthcare providers and clinical partners seeking alternatives to antibiotic-dependent wound management.

Contract development and manufacture of nanofibrous biomaterials for medical devices

The Electrospinning Company designs, develops, and manufactures nanofibrous biomaterials for implantable medical devices and regenerative medicine applications. Using electrospinning technology, the company produces four proprietary membrane platforms: resorbable Mimetix, permanent Kalyptix, biosynthetic Symatix, and the Caladrix device-coating system. Services span early feasibility through to validated commercial-scale manufacturing under ISO 13485 accreditation, supporting clients across cardiovascular, orthopaedic, wound care, and ophthalmology applications. The company operates from a purpose-built cleanroom facility on Harwell Campus.

Electrospun biomimetic scaffold platform for wound repair

Corryn Biotechnologies is a Welsh biotechnology company developing an electrospinning platform that fabricates nano- and microfibrous polymer scaffolds directly onto wound sites at the point of care. The resorbable scaffolds mimic the architecture of the extracellular matrix, supporting tissue regeneration in chronic and complex wounds. Delivered via a handheld applicator device, the platform is pre-clinical and advancing toward first-in-human studies, with applications extending to infection detection and drug delivery.

Plant-based molecular farming platform for bio-identical collagen production

LeafyColl is a biotech developing a molecular farming platform for the scalable, plant-based production of bio-identical human collagen and other specialty proteins. The system uses engineered plants as programmable bio-factories to produce high-purity collagen for applications spanning regenerative medicine, wound care, nutraceuticals, and cosmetic formulations. The plant-derived production route eliminates animal and microbial feedstocks, delivering a vegan, GMO-free ingredient with structural equivalence to human collagen.

Asymmetric biomaterial skin substitutes for acute and chronic wounds

Janus Biosciences is a biotech developing novel biomaterial skin substitutes for the treatment of acute and chronic wounds. The platform is based on asymmetric Janus material architectures, in which opposing faces of the scaffold present distinct physicochemical properties to simultaneously support wound bed healing and provide external barrier protection. The company's goal is to produce universally compatible, widely accessible skin substitutes applicable across a range of wound types and clinical settings.

Global medical technology company specialising in chronic condition management

Convatec is a global medical products and technologies company focused on chronic condition management. The group develops and manufactures advanced wound care dressings, ostomy care, continence care and infusion care products, including hydrofiber-based, antimicrobial and tissue-derived biomaterial wound dressings supported by clinical research and evidence generation. Convatec serves hospitals, community healthcare providers and patients managing long-term conditions, and is expanding its manufacturing and research and development operations within the UK.